KRAS and acute promyelocytic leukemia: Lastly, a 5-mutational biomarker panel (APC, Bat-26, KRAS, L-DNA, and p53) achieved slightly improved sensitivity for APL at 82.0%, with high performance for overall CRC detection (91% sensitivity, 93% specificity), highlighting its diagnostic potential [38].